• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    OEM Patient Monitoring Vital Sign OEM Module Market

    ID: MRFR/MED/9952-CR
    128 Pages
    Rahul Gotadki
    March 2023

    OEM Patient Monitoring and Vital Sign OEM Module Market Research Report Information by Product Type (Hemodynamic Monitoring Devices [Blood Glucose, Cholesterol, Blood Gas & Electrolyte Analyzers/Monitors, Blood Pressure], Neuromonitoring Devices [Electroencephalograph (EEG) Devices, Magnetoencephalograph (MEG) Devices, Intracranial Pressure Monitors (ICP), Transcranial Dopplers (TCD), Cerebral Oximeters, and Near-infrared spectroscopy (NIRS)], Cardiac Monitoring Devices [Electrocardiogram (ECG) Devices, Implantable Loop Recorders (ILR), ...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    OEM Patient Monitoring and Vital Sign OEM Module Market Research Report—Global Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    OEM Patient Monitoring Vital Sign OEM Module Market Summary

    The Global OEM Patient Monitoring and Vital Sign OEM Module Market is projected to grow from 12.6 USD Billion in 2024 to 27.9 USD Billion by 2035.

    Key Market Trends & Highlights

    OEM Patient Monitoring and Vital Sign OEM Module Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 7.47 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 27.9 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 12.6 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced monitoring technologies due to increasing demand for patient safety is a major market driver.

    Market Size & Forecast

    2024 Market Size 12.6 (USD Billion)
    2035 Market Size 27.9 (USD Billion)
    CAGR (2025-2035) 7.47%

    Major Players

    Sentec AG (Switzerland), Medtronic Plc (Ireland), Nonin Medical Inc. (US), Masimo Corporation (US), Ronseda Electronics Co., Ltd (China), Triton Electronic Systems Ltd (Russia), Halma Plc (UK), Zug Medical System SAS (France), Fresenius Kabi AG (Germany), Smiths Group plc (UK)

    OEM Patient Monitoring Vital Sign OEM Module Market Trends

      • Growing demand for wearable devices boosts market growth.

    The growing need for wearable patient monitoring devices is crucial for continuous temperature monitoring, glucose monitoring, pulse oximetry, biosensors, and blood pressure monitoring. These are some of the features of wearable patient monitoring devices. Additionally, the Internet of Things connects these features to wearable patient monitoring devices due to the wide range of applications. Moreover, the rapid development of the IoT makes it easy to monitor patient information. For example, in July 2020, Medtronic plc (Ireland) received US Food Drug and Administration and Conformité Européenne (CE) clearances for its LINQ II Insertable Cardiac Monitor (ICM).

    LINQ II is a small wireless ICM for patients with abnormal heart rhythms and for those who require long-term monitoring.

    Furthermore, technological advancements in patient monitoring devices are expected to accelerate market growth in the future. Amid the rising demand for the latest technology to be used in patient monitoring devices, the OEM companies have started investing a huge amount in their R&D activities in developing advanced modules & components of patient monitoring and vital sign monitoring system. For instance, in July 2021, VoCare, Inc. (US), launched Vital360, an all-in-one, handheld patient health monitoring device. Vital360 is an advanced grade health monitoring tool that combines multiple biometric measurements in a single handheld device.

    Such advancements are likely to accelerate the market growth of patient monitoring devices in the future.

    The ongoing evolution of technology in healthcare is likely to enhance the capabilities of OEM patient monitoring systems, thereby improving patient outcomes and operational efficiencies in medical settings.

    U.S. Food and Drug Administration (FDA)

    OEM Patient Monitoring Vital Sign OEM Module Market Drivers

    Aging Population

    The Global OEM Patient Monitoring and Vital Sign OEM Module Market Industry is significantly influenced by the aging population, which is leading to an increased prevalence of chronic diseases. As individuals age, they often require more frequent monitoring of vital signs to manage health conditions effectively. This demographic shift is driving demand for advanced monitoring solutions that can provide continuous and accurate health data. According to projections, the market is expected to grow to 27.9 USD Billion by 2035, highlighting the necessity for innovative patient monitoring technologies tailored to the needs of older adults.

    Market Growth Projections

    The Global OEM Patient Monitoring and Vital Sign OEM Module Market Industry is poised for substantial growth, with projections indicating a market size of 12.6 USD Billion in 2024 and an anticipated increase to 27.9 USD Billion by 2035. The compound annual growth rate (CAGR) is estimated at 7.47% from 2025 to 2035, reflecting the increasing demand for advanced patient monitoring solutions. This growth trajectory is influenced by various factors, including technological advancements, an aging population, and rising healthcare expenditures. The market's expansion underscores the critical role of OEM modules in enhancing patient care and operational efficiency across healthcare settings.

    Technological Advancements

    The Global OEM Patient Monitoring and Vital Sign OEM Module Market Industry is experiencing rapid technological advancements, which enhance the capabilities of monitoring devices. Innovations such as wireless connectivity, cloud computing, and artificial intelligence are becoming increasingly integrated into patient monitoring systems. These advancements facilitate real-time data transmission and analysis, improving patient outcomes and operational efficiency. For instance, the incorporation of AI algorithms allows for predictive analytics, enabling healthcare providers to anticipate patient needs. As a result, the market is projected to reach 12.6 USD Billion in 2024, reflecting the growing demand for sophisticated monitoring solutions.

    Rising Healthcare Expenditure

    Increased healthcare expenditure globally is a critical driver for the Global OEM Patient Monitoring and Vital Sign OEM Module Market Industry. Governments and private sectors are investing more in healthcare infrastructure, which includes the acquisition of advanced patient monitoring systems. This trend is particularly evident in developing countries, where healthcare budgets are expanding to improve service delivery. The rise in spending is likely to enhance the adoption of OEM modules that offer integrated monitoring solutions, thereby contributing to a projected CAGR of 7.47% from 2025 to 2035. This growth underscores the importance of investing in modern healthcare technologies.

    Focus on Preventive Healthcare

    The Global OEM Patient Monitoring and Vital Sign OEM Module Market Industry is increasingly shaped by a focus on preventive healthcare. Healthcare providers are shifting from reactive to proactive approaches, emphasizing early detection and management of health issues. This paradigm shift is driving the demand for patient monitoring systems that can provide continuous health data, enabling timely interventions. As healthcare systems prioritize preventive measures, the market is likely to expand, supported by innovations in monitoring technology that facilitate real-time health assessments. This trend aligns with the overall growth trajectory of the market, which is expected to reach substantial figures in the coming years.

    Integration of Telehealth Services

    The integration of telehealth services is emerging as a significant driver in the Global OEM Patient Monitoring and Vital Sign OEM Module Market Industry. Telehealth facilitates remote patient monitoring, allowing healthcare providers to track vital signs and health metrics without the need for in-person visits. This integration not only enhances patient convenience but also optimizes resource allocation within healthcare systems. As telehealth continues to gain traction, the demand for OEM modules that support remote monitoring capabilities is likely to increase. This trend is indicative of a broader shift towards digital health solutions, which are expected to play a crucial role in the market's growth.

    Market Segment Insights

    Get more detailed insights about OEM Patient Monitoring and Vital Sign OEM Module Market Research Report—Global Forecast till 2032

    Request Free Sample

    Regional Insights

    By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. North America OEM patient monitoring and vital sign OEM module market accounted for the largest market share in 2021, owing to increasing cases of cardiovascular diseases, high adoption of patient monitoring devices, and well-established healthcare infrastructure. According to the Centers for Disease Control and Prevention (CDC), more than 750,000 hospitalizations occur each year because of atrial fibrillation in the US.

    Furthermore, according to the American Heart Association Research Report 2018, heart disease is the leading cause of death in the US, accounting for one in every seven deaths.

    Further, the major countries studied are: The US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 3: OEM PATIENT MONITORING AND VITAL SIGN OEM MODULE MARKET BY REGION 2022 & 2032OEM PATIENT MONITORING AND VITAL SIGN OEM MODULE MARKET BY REGION 2021 & 2030

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Europe OEM patient monitoring and vital sign OEM module market accounts for the second-largest market share due to increase in funding and initiatives for research & development, an increase in adoption of advanced OEM technologies, the prevalence of neurological diseases, and an increase in the number of new product launch by market players are driving the growth of the market in the region.

    Furthermore, the Germany market of OEM patient monitoring and vital sign OEM module held the largest market share in 2021, and the UK market of OEM patient monitoring and vital sign OEM module is the fastest growing market in the Europe region.

    The Asia-Pacific OEM patient monitoring and vital sign OEM module market is expected to grow at a significant share from 2024 to 2032 due to the factors such as presence of big OEM modules and component manufacturers, increasing medical tourism in the region. Moreover, China market of OEM patient monitoring and vital sign OEM module held the largest market share in 2021, and the India market of OEM patient monitoring and vital sign OEM module is the fastest growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Major market players are spending a lot of money on R&D to increase their product lines, which will help the market of OEM patient monitoring and vital sign OEM module grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the OEM patient monitoring and vital sign OEM module industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

    Sentec AG (Switzerland) is a Swiss medical equipment manufacturing company, which expertise in technologies and products for noninvasive patient monitoring. Sentec AG manufactures digital, integrated sensors, which provide noninvasive, continuous ventilation and oxygenation monitoring. Swisstom (Switzerland), a subsidiary of Sentec AG, offers products smaller in size that can fit into the small spaces of monitor anesthesia machine and ventilator. In December 2018, the company acquired Swisstom. This acquired enhanced Sentec's product and service offering.

    Key Companies in the OEM Patient Monitoring Vital Sign OEM Module Market market include

    Industry Developments

    September 2021: Suntech Medical Inc. (US), a subsidiary of Halma plc (UK), acquired Meditech KFT (Hungary), a manufacturer of ambulatory blood pressure monitors based in Budapest, Hungary.January 2020: Suntech Medical Inc. (US) collaborated with Valencell Inc. (US), a leader in manufacturing biometric sensors for wearables, to provide better BP measurement devices.

    Future Outlook

    OEM Patient Monitoring Vital Sign OEM Module Market Future Outlook

    The OEM Patient Monitoring and Vital Sign OEM Module Market is projected to grow at a 7.47% CAGR from 2024 to 2035, driven by technological advancements, increasing demand for remote monitoring, and regulatory support.

    New opportunities lie in:

    • Develop AI-driven analytics for predictive patient monitoring solutions.
    • Expand partnerships with telehealth providers to enhance service offerings.
    • Invest in customizable modules to meet diverse healthcare provider needs.

    By 2035, the market is expected to exhibit robust growth, positioning itself as a cornerstone of modern healthcare solutions.

    Market Segmentation

    OEM Patient Monitoring and Vital Sign OEM Module Regional Outlook

    North America
    • US
    • Canada

    OEM Patient Monitoring and Vital Sign OEM Module Product Type Outlook

    Hemodynamic Monitoring Devices
    • Blood Glucose
    • Cholesterol
    • Blood Gas & Electrolyte Analyzers/Monitors
    • Blood Pressure

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 USD 12.23 billion
    Market Size 2024 USD 12.62 billion
    Market Size 2032 USD 23.17 billion
    Compound Annual Growth Rate (CAGR) 6.36% (2024-2032)
    Base Year 2023
    Forecast Period 2024-2032
    Historical Data 2018 & 2022
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product Type and Region
    Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
    Countries Covered The US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Sentec AG (Switzerland), Medtronic Plc (Ireland), Nonin Medical Inc. (US), Masimo Corporation (US), Ronseda Electronics Co., Ltd (China), Triton Electronic Systems Ltd (Russia), Halma Plc (UK), Zug Medical System SAS (France), Fresenius Kabi AG (Germany), Smiths Group plc (UK), and Others
    Key Market Opportunities ·       Growing demand for patient monitoring devices in non-hospital settings
    Key Market Drivers ·       Growing demand for wearable devices ·       Increasing demand for continuous patient monitoring devices

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    How much is the OEM patient monitoring and vital sign OEM module market?

    The OEM Patient Monitoring and Vital Sign OEM Module Market is anticipated to reach 23.17 billion at a CAGR of 6.36% during the forecast period of 2024-2032.

    How big is the US OEM patient monitoring and vital sign OEM module market?

    The US is expected to hold a 91.55% share of the global market for OEM patient monitoring and vital sign OEM module market during the forecast period of 2024-2032.

    What is the growth rate of the OEM patient monitoring and vital sign OEM Module Market?

    The OEM patient monitoring and vital sign OEM module market is expected to grow at a 6.36% CAGR during the forecast period from 2024 to 2032.

    Which region held the largest market share in the OEM patient monitoring and vital sign OEM module market?

    The North America region market held the largest market share in OEM patient monitoring and vital sign OEM module market.

    Who are the key players in the OEM patient monitoring and vital sign OEM module market?

    The key players include Sentec AG (Switzerland), Medtronic Plc (Ireland), Nonin Medical Inc. (US), Masimo Corporation (US), Ronseda Electronics Co., Ltd (China), Triton Electronic Systems Ltd (Russia), Halma Plc (UK), Zug Medical System SAS (France), Fresenius Kabi AG (Germany), Smiths Group plc (UK), and Others.

    Which product type led the OEM patient monitoring and vital sign OEM module market?

    The hemodynamic monitoring devices product type led the OEM patient monitoring and vital sign OEM module market.

    1. EXECUTIVE SUMMARY
    2. MARKET INTRODUCTION
      1. DEFINITION
      2. SCOPE OF THE STUDY
      3. RESEARCH OBJECTIVE
    3. MARKET STRUCTURE
      1. ASSUMPTIONS & LIMITATIONS
    4. RESEARCH METHODOLOGY
      1. DATA MINING
      2. SECONDARY RESEARCH
      3. PRIMARY RESEARCH
    5. BREAKDOWN OF PRIMARY RESPONDENTS
      1. FORECASTING TECHNIQUES
      2. RESEARCH
    6. METHODOLOGY FOR MARKET SIZE ESTIMATION
      1. BOTTOM-UP APPROACH
    7. TOP-DOWN APPROACH
      1. DATA TRIANGULATION
      2. VALIDATION
    8. MARKET
    9. DYNAMICS
      1. OVERVIEW
      2. DRIVERS
        1. GROWING DEMAND FOR WEARABLE
    10. DEVICES
      1. INCREASING DEMAND FOR CONTINUOUS PATIENT MONITORING DEVICES
        1. TECHNOLOGICAL ADVANCEMENT IN PATIENT MONITORING DEVICES
      2. RESTRAINTS
        1. DEMAND AND SUPPLY GAP OF OEM PATIENT MONITORING AND VITAL SIGN MODULES
        2. STRINGENT RULES AND REGULATIONS FOR PRODUCT APPROVAL
      3. OPPORTUNITIES
        1. GROWING DEMAND FOR PATIENT MONITORING DEVICES IN NON-HOSPITAL SETTINGS
      4. PRICING ANALYSIS, BY PRODUCT TYPE (USD), 2020
    11. MARKET FACTOR ANALYSIS
      1. VALUE CHAIN ANALYSIS
        1. R&D
        2. MANUFACTURING
    12. DISTRIBUTION AND SALES
      1. POST-SALES MONITORING
      2. PORTER'S FIVE FORCES
    13. MODEL
      1. THREAT OF NEW ENTRANTS
        1. BARGAINING POWER OF SUPPLIERS
        2. THREAT OF SUBSTITUTES
        3. BARGAINING POWER OF BUYERS
        4. INTENSITY
    14. OF RIVALRY
      1. IMPACT OF COVID-19 ON THE OEM PATIENT MONITORING AND VITAL SIGN
    15. MODULES MARKET
      1. IMPACT ON SUPPLY CHAIN
        1. IMPACT ON PRODUCTION
        2. IMPACT ON MARKET
        3. IMPACT ON SALES/REVENUE
    16. GLOBAL OEM PATIENT
    17. MONITORING AND VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE
      1. OVERVIEW
      2. HEMODYNAMIC MONITORING DEVICES
        1. BLOOD GLUCOSE
        2. CHOLESTEROL
        3. BLOOD GAS & ELECTROLYTE ANALYZERS/MONITORS
        4. BLOOD PRESSURE
      3. NEUROMONITORING DEVICES
        1. ELECTROENCEPHALOGRAPH (EEG) DEVICES
        2. MAGNETOENCEPHALOGRAPH (MEG) DEVICES
        3. INTRACRANIAL PRESSURE MONITORS
    18. (ICP)
      1. TRANSCRANIAL DOPPLERS (TCD)
        1. CEREBRAL OXIMETERS
    19. NEAR-INFRARED SPECTROSCOPY (NIRS)
      1. CARDIAC MONITORING DEVICES
    20. ELECTROCARDIOGRAM (ECG) DEVICES
      1. IMPLANTABLE LOOP RECORDERS (ILR)
    21. CARDIAC OUTPUT MONITORING (COM) DEVICES
      1. EVENT MONITORS
      2. FETAL
    22. & NEONATAL MONITORING DEVICES
      1. ULTRASOUND
        1. ELECTRONIC FETAL
    23. MONITORING DEVICES
      1. FETAL DOPPLER MONITORING DEVICES
        1. OTHER
    24. FETAL & NEONATAL MONITORING DEVICES
      1. RESPIRATORY MONITORING DEVICES
        1. DEVICE TYPE
    25. DEVICES
      1. DISEASE INDICATION
        1. COPD
      2. REMOTE PATIENT MONITORING DEVICES
      3. TEMPERATURE MONITORING DEVICES
      4. OTHERS
    26. GLOBAL OEM PATIENT MONITORING
    27. AND VITAL SIGNS MODULES MARKET, BY REGION
      1. OVERVIEW
      2. NORTH AMERICA
        1. US
        2. CANADA
      3. EUROPE
        1. GERMANY
        2. FRANCE
        3. UK
        4. ITALY
        5. SPAIN
        6. REST OF EUROPE
    28. ASIA-PACIFIC
      1. CHINA
        1. JAPAN
        2. INDIA
        3. AUSTRALIA
        4. SOUTH KOREA
        5. REST OF ASIA-PACIFIC
      2. REST OF THE WORLD
        1. MIDDLE EAST
        2. AFRICA
        3. LATIN AMERICA
    29. COMPETITIVE LANDSCAPE
      1. OVERVIEW
      2. KEY DEVELOPMENT ANALYSIS
      3. MAJOR GROWTH
    30. STRATEGY IN THE OEM PATIENT MONITORING MARKET AND GLOBAL VITAL SIGN OEM MODULE MARKET
      1. COMPETITIVE BENCHMARKING
      2. MARKET SHARE ANALYSIS OF OEM PATIENT MONITORING
    31. AND VITAL SIGNS MODULE MARKET
      1. MARKET SHARE ANALYSIS FOR OEM SPO2
    32. MARKET SHARE ANALYSIS FOR COPD
      1. MARKET SHARE ANALYSIS FOR SLEEP APNEA
      2. MARKET SHARE ANALYSIS FOR ASTHMA
      3. THE LEADING PLAYER IN TERMS OF
    33. NUMBER OF DEVELOPMENTS IN THE OEM PATIENT MONITORING MARKET AND GLOBAL VITAL SIGN
    34. OEM MODULE MARKET
      1. KEY DEVELOPMENTS & GROWTH STRATEGIES
    35. PARTNERSHIP/COLLABORATION
      1. MERGERS & ACQUISITIONS
      2. MAJOR
    36. PLAYERS FINANCIALS
      1. SALES & OPERATING INCOME
        1. MAJOR PLAYERS
    37. R&D ANALYSIS
    38. COMPANY PROFILES
      1. MEDTRONIC PLC
        1. COMPANY
    39. OVERVIEW
      1. FINANCIAL OVERVIEW
        1. PRODUCTS/SERVICES OFFERED
    40. KEY DEVELOPMENTS
      1. SWOT ANALYSIS
        1. KEY STRATEGIES
      2. NONIN
    41. MEDICAL INC.
      1. COMPANY OVERVIEW
        1. FINANCIAL OVERVIEW
    42. PRODUCTS/SERVICES OFFERED
      1. KEY DEVELOPMENTS
        1. SWOT ANALYSIS
        2. KEY STRATEGIES
      2. MASIMO CORPORATION
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      3. RONSEDA ELECTRONICS CO.,
    43. LTD.
      1. COMPANY OVERVIEW
        1. FINANCIAL OVERVIEW
        2. PRODUCTS/SERVICES
    44. OFFERED
      1. KEY DEVELOPMENTS
        1. KEY STRATEGIES
      2. TRITON ELECTRONIC
    45. SYSTEMS LTD
      1. COMPANY OVERVIEW
        1. FINANCIAL OVERVIEW
    46. PRODUCTS/SERVICES OFFERED
      1. KEY DEVELOPMENTS
        1. KEY STRATEGIES
      2. HALMA PLC (SUNTECH MEDICAL)
        1. COMPANY OVERVIEW
        2. FINANCIAL
    47. OVERVIEW
      1. PRODUCTS/SERVICES OFFERED
        1. KEY DEVELOPMENTS
    48. KEY STRATEGIES
      1. SENTEC AG (SWISSTOM AG)
        1. COMPANY OVERVIEW
    49. FINANCIAL OVERVIEW
      1. PRODUCTS/SERVICES OFFERED
        1. KEY DEVELOPMENTS
        2. KEY STRATEGIES
      2. ZUG MEDICAL SYSTEM SAS
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      3. FRESENIUS KABI (QUANTIUM MEDICAL)
        1. COMPANY
    50. OVERVIEW
      1. FINANCIAL OVERVIEW
        1. PRODUCTS/SERVICES OFFERED
    51. KEY DEVELOPMENTS
      1. SWOT ANALYSIS
        1. KEY STRATEGIES
      2. SMITHS
    52. GROUP PLC (SMITH MEDICAL)
      1. COMPANY OVERVIEW
        1. FINANCIAL OVERVIEW
        2. PRODUCTS/SERVICES OFFERED
        3. KEY DEVELOPMENTS
        4. SWOT
    53. ANALYSIS
      1. KEY STRATEGIES
    54. APPENDIX
      1. REFERENCES
    55. RELATED REPORTS
    56. & LIMITATIONS
    57. AND VITAL SIGNS MODULE MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
    58. GLOBAL: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR HEMODYNAMIC
    59. MONITORING DEVICES, BY REGION, 2018–2027 (USD MILLION)
    60. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR HEMODYNAMIC MONITORING
    61. DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    62. MONITORING AND VITAL SIGNS MODULES MARKET, FOR BLOOD GLUCOSE, BY REGION, 2018–2027
    63. (USD MILLION)
    64. MARKET, FOR CHOLESTEROL, BY REGION, 2018–2027 (USD MILLION)
    65. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR BLOOD GAS & ELECTROLYTE
    66. ANALYZERS/MONITORS, BY REGION, 2018–2027 (USD MILLION)
    67. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR BLOOD PRESSURE, BY REGION,
    68. –2027 (USD MILLION)
    69. SIGNS MODULES MARKET, FOR NEUROMONITORING DEVICES, BY REGION, 2018–2027 (USD
    70. MILLION)
    71. FOR NEUROMONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    72. GLOBAL: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR ELECTROENCEPHALOGRAPH
    73. (EEG) DEVICES, BY REGION, 2018–2027 (USD MILLION)
    74. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR MAGNETOENCEPHALOGRAPH (MEG)
    75. DEVICES, BY REGION, 2018–2027 (USD MILLION)
    76. MONITORING AND VITAL SIGNS MODULES MARKET, FOR INTRACRANIAL PRESSURE MONITORS (ICP),
    77. BY REGION, 2018–2027 (USD MILLION)
    78. AND VITAL SIGNS MODULES MARKET, FOR TRANSCRANIAL DOPPLERS (TCD), BY REGION, 2018–2027
    79. (USD MILLION)
    80. MARKET, FOR CEREBRAL OXIMETERS, BY REGION, 2018–2027 (USD MILLION)
    81. GLOBAL: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR NEAR-INFRARED
    82. SPECTROSCOPY (NIRS), BY REGION, 2018–2027 (USD MILLION)
    83. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR CARDIAC MONITORING DEVICES,
    84. BY REGION, 2018–2027 (USD MILLION)
    85. AND VITAL SIGNS MODULES MARKET, FOR CARDIAC MONITORING DEVICES, BY TYPE, 2018–2027
    86. (USD MILLION)
    87. MARKET, FOR ELECTROCARDIOGRAM (ECG) DEVICES, BY REGION, 2018–2027 (USD MILLION)
    88. LOOP RECORDERS (ILR), BY REGION, 2018–2027 (USD MILLION)
    89. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR CARDIAC OUTPUT MONITORING
    90. (COM) DEVICES, BY REGION, 2018–2027 (USD MILLION)
    91. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR EVENT MONITORS, BY REGION,
    92. –2027 (USD MILLION)
    93. SIGNS MODULES MARKET, FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2018–2027
    94. (USD MILLION)
    95. MARKET, FOR FETAL & NEONATAL MONITORING DEVICES, BY TYPE, 2018–2027 (USD
    96. MILLION)
    97. FOR ULTRASOUND, BY REGION, 2018–2027 (USD MILLION)
    98. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR ELECTRONIC FETAL MONITORING
    99. DEVICES, BY REGION, 2018–2027 (USD MILLION)
    100. MONITORING AND VITAL SIGNS MODULES MARKET, FOR FETAL DOPPLER MONITORING DEVICES,
    101. BY REGION, 2018–2027 (USD MILLION)
    102. AND VITAL SIGNS MODULES MARKET, FOR OTHER FETAL & NEONATAL MONITORING DEVICES,
    103. BY REGION, 2018–2027 (USD MILLION)
    104. AND VITAL SIGNS MODULES MARKET, FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2018–2027
    105. (USD MILLION)
    106. MARKET, RESPIRATORY MONITORING DEVICES, BY DEVICE TYPE, 2018–2027 (USD MILLION)
    107. BY REGION, 2018–2027 (USD MILLION)
    108. AND VITAL SIGNS MODULES MARKET, FOR ANESTHESIA MONITORS, BY REGION, 2018–2027
    109. (USD MILLION)
    110. MARKET, FOR SPIROMETERS, BY REGION, 2018–2027 (USD MILLION)
    111. GLOBAL: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR PULSE OXIMETERS,
    112. BY REGION, 2018–2027 (USD MILLION)
    113. AND VITAL SIGNS MODULES MARKET, FOR PULSE OXIMETERS, BY REGION, 2018–2027
    114. (UNITS)
    115. FOR SLEEP APNEA MONITORING DEVICES, BY REGION, 2018–2027 (USD MILLION)
    116. MONITORING DEVICES, BY DISEASE INDICATION, 2018–2027 (USD MILLION)
    117. GLOBAL: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR COPD, BY REGION,
    118. –2027 (USD MILLION)
    119. SIGNS MODULES MARKET, FOR SLEEP APNEA, BY REGION, 2018–2027 (USD MILLION)
    120. BY REGION, 2018–2027 (USD MILLION)
    121. AND VITAL SIGNS MODULES MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)
    122. PATIENT MONITORING DEVICES, BY REGION, 2018–2027 (USD MILLION)
    123. GLOBAL: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR TEMPERATURE
    124. MONITORING DEVICES, BY REGION, 2018–2027 (USD MILLION)
    125. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR OTHERS, BY REGION, 2018–2027
    126. (USD MILLION)
    127. MARKET SHARE, BY REGION, 2018–2027 (USD MILLION)
    128. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE, 2018–2027
    129. (USD MILLION)
    130. MARKET FOR HEMODYNAMIC MONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    131. DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    132. MONITORING AND VITAL SIGNS MODULES MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE,
    133. –2027 (USD MILLION)
    134. SIGNS MODULES MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY TYPE, 2018–2027
    135. (USD MILLION)
    136. MARKET FOR RESPIRATORY MONITORING DEVICES, BY DEVICE TYPE, 2018–2027 (USD
    137. MILLION)
    138. FOR RESPIRATORY MONITORING DEVICES, BY DISEASE INDICATION, 2018–2027 (USD
    139. MILLION)
    140. MARKET, BY REGION, 2018–2027 (USD MILLION)
    141. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE, 2018–2027
    142. (USD MILLION)
    143. MODULES MARKET FOR HEMODYNAMIC MONITORING DEVICES, BY TYPE, 2018–2027 (USD
    144. MILLION)
    145. MARKET FOR NEUROMONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    146. NORTH AMERICA: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR CARDIAC
    147. MONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    148. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR FETAL & NEONATAL MONITORING
    149. DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    150. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR RESPIRATORY MONITORING DEVICES,
    151. BY DEVICE TYPE, 2018–2027 (USD MILLION)
    152. MONITORING AND VITAL SIGNS MODULES MARKET FOR RESPIRATORY MONITORING DEVICES, BY
    153. DISEASE INDICATION, 2018–2027 (USD MILLION)
    154. MONITORING AND VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE, 2018–2027 (USD
    155. MILLION)
    156. FOR HEMODYNAMIC MONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    157. US: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR NEUROMONITORING
    158. DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    159. AND VITAL SIGNS MODULES MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE, 2018–2027
    160. (USD MILLION)
    161. FOR FETAL & NEONATAL MONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    162. MONITORING DEVICES, BY DEVICE TYPE, 2018–2027 (USD MILLION)
    163. US: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR RESPIRATORY MONITORING
    164. DEVICES, BY DISEASE INDICATION, 2018–2027 (USD MILLION)
    165. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE, 2018–2027
    166. (USD MILLION)
    167. MARKET FOR HEMODYNAMIC MONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    168. DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    169. MONITORING AND VITAL SIGNS MODULES MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE,
    170. –2027 (USD MILLION)
    171. SIGNS MODULES MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY TYPE, 2018–2027
    172. (USD MILLION)
    173. MARKET FOR RESPIRATORY MONITORING DEVICES, BY DEVICE TYPE, 2018–2027 (USD
    174. MILLION)
    175. FOR RESPIRATORY MONITORING DEVICES, BY DISEASE INDICATION, 2018–2027 (USD
    176. MILLION)
    177. BY COUNTRY, 2018–2027 (USD MILLION)
    178. AND VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    179. MONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    180. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR NEUROMONITORING DEVICES,
    181. BY TYPE, 2018–2027 (USD MILLION)
    182. AND VITAL SIGNS MODULES MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE, 2018–2027
    183. (USD MILLION)
    184. MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY TYPE, 2018–2027 (USD
    185. MILLION)
    186. FOR RESPIRATORY MONITORING DEVICES, BY DEVICE TYPE, 2018–2027 (USD MILLION)
    187. MONITORING DEVICES, BY DISEASE INDICATION, 2018–2027 (USD MILLION)
    188. GERMANY : OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE,
    189. –2027 (USD MILLION)
    190. VITAL SIGNS MODULES MARKET FOR HEMODYNAMIC MONITORING DEVICES, BY TYPE, 2018–2027
    191. (USD MILLION)
    192. MARKET FOR NEUROMONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    193. GERMANY: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR CARDIAC MONITORING
    194. DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    195. MONITORING AND VITAL SIGNS MODULES MARKET FOR FETAL & NEONATAL MONITORING DEVICES,
    196. BY TYPE, 2018–2027 (USD MILLION)
    197. AND VITAL SIGNS MODULES MARKET FOR RESPIRATORY MONITORING DEVICES, BY DEVICE TYPE,
    198. –2027 (USD MILLION)
    199. VITAL SIGNS MODULES MARKET FOR RESPIRATORY MONITORING DEVICES, BY DISEASE INDICATION,
    200. –2027 (USD MILLION)
    201. VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    202. FRANCE: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR HEMODYNAMIC
    203. MONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    204. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR NEUROMONITORING DEVICES,
    205. BY TYPE, 2018–2027 (USD MILLION)
    206. AND VITAL SIGNS MODULES MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE, 2018–2027
    207. (USD MILLION)
    208. MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY TYPE, 2018–2027 (USD
    209. MILLION)
    210. FOR RESPIRATORY MONITORING DEVICES, BY DEVICE TYPE, 2018–2027 (USD MILLION)
    211. MONITORING DEVICES, BY DISEASE INDICATION, 2018–2027 (USD MILLION)
    212. UK : OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE,
    213. –2027 (USD MILLION)
    214. SIGNS MODULES MARKET FOR HEMODYNAMIC MONITORING DEVICES, BY TYPE, 2018–2027
    215. (USD MILLION)
    216. MARKET FOR NEUROMONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    217. UK: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR CARDIAC MONITORING
    218. DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    219. AND VITAL SIGNS MODULES MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY TYPE,
    220. –2027 (USD MILLION)
    221. SIGNS MODULES MARKET FOR RESPIRATORY MONITORING DEVICES, BY DEVICE TYPE, 2018–2027
    222. (USD MILLION)
    223. MARKET FOR RESPIRATORY MONITORING DEVICES, BY DISEASE INDICATION, 2018–2027
    224. (USD MILLION)
    225. MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    226. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR HEMODYNAMIC MONITORING DEVICES,
    227. BY TYPE, 2018–2027 (USD MILLION)
    228. AND VITAL SIGNS MODULES MARKET FOR NEUROMONITORING DEVICES, BY TYPE, 2018–2027
    229. (USD MILLION)
    230. MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    231. & NEONATAL MONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    232. ITALY: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR RESPIRATORY
    233. MONITORING DEVICES, BY DEVICE TYPE, 2018–2027 (USD MILLION)
    234. ITALY: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR RESPIRATORY MONITORING
    235. DEVICES, BY DISEASE INDICATION, 2018–2027 (USD MILLION)
    236. : OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE, 2018–2027
    237. (USD MILLION)
    238. MARKET FOR HEMODYNAMIC MONITORING DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    239. DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    240. MONITORING AND VITAL SIGNS MODULES MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE,
    241. –2027 (USD MILLION)
    242. SIGNS MODULES MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY TYPE, 2018–2027
    243. (USD MILLION)
    244. MARKET FOR RESPIRATORY MONITORING DEVICES, BY DEVICE TYPE, 2018–2027 (USD
    245. MILLION)
    246. FOR RESPIRATORY MONITORING DEVICES, BY DISEASE INDICATION, 2018–2027 (USD
    247. MILLION)
    248. MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    249. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR HEMODYNAMIC MONITORING
    250. DEVICES, BY TYPE, 2018–2027 (USD MILLION)
    251. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR NEUROMONITORING DEVICES, BY
    252. TYPE, 2018–2027 (USD MILLION)
    253. AND VITAL SIGNS MODULES MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE, 2018–2027
    254. (USD MILLION)
    255. MODULES MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY TYPE, 2018–2027
    256. (USD MILLION)
    257. MODULES MARKET FOR RESPIRATORY MONITORING DEVICES, BY DEVICE TYPE, 2018–2027
    258. (USD MILLION)
    259. MODULES MARKET FOR RESPIRATORY MONITORING DEVICES, BY DISEASE INDICATION, 2018–2027
    260. (USD MILLION)
    261. MODULES MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
    262. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE, 2018–2027
    263. (USD MILLION)
    264. MODULES MARKET, FOR HEMODYNAMIC MONITORING DEVICES, BY PRODUCT TYPE, 2018–2027
    265. (USD MILLION)
    266. MODULES MARKET, FOR NEUROMONITORING DEVICES, BY PRODUCT TYPE, 2018–2027 (USD
    267. MILLION)
    268. MARKET, FOR CARDIAC MONITORING DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    269. FOR FETAL & NEONATAL MONITORING DEVICES, BY PRODUCT TYPE, 2018–2027 (USD
    270. MILLION)
    271. MARKET, BY DEVICE TYPE, 2018–2027 (USD MILLION)
    272. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR RESPIRATORY MONITORING
    273. DEVICES, BY DISEASE INDICATION, 2018–2027 (USD MILLION)
    274. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE, 2018–2027
    275. (USD MILLION)
    276. MARKET, FOR HEMODYNAMIC MONITORING DEVICES, BY PRODUCT TYPE, 2018–2027 (USD
    277. MILLION)
    278. FOR NEUROMONITORING DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    279. CHINA: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR CARDIAC MONITORING
    280. DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    281. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR FETAL & NEONATAL MONITORING
    282. DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    283. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, BY DEVICE TYPE, 2018–2027
    284. (USD MILLION)
    285. MARKET FOR RESPIRATORY MONITORING DEVICES, BY DISEASE INDICATION, 2018–2027
    286. (USD MILLION)
    287. MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    288. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR HEMODYNAMIC MONITORING DEVICES,
    289. BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    290. MONITORING AND VITAL SIGNS MODULES MARKET, FOR NEUROMONITORING DEVICES, BY PRODUCT
    291. TYPE, 2018–2027 (USD MILLION)
    292. AND VITAL SIGNS MODULES MARKET, FOR CARDIAC MONITORING DEVICES, BY PRODUCT TYPE,
    293. –2027 (USD MILLION)
    294. SIGNS MODULES MARKET, FOR FETAL & NEONATAL MONITORING DEVICES, BY PRODUCT TYPE,
    295. –2027 (USD MILLION)
    296. SIGNS MODULES MARKET, BY DEVICE TYPE, 2018–2027 (USD MILLION)
    297. JAPAN: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR RESPIRATORY MONITORING
    298. DEVICES, BY DISEASE INDICATION, 2018–2027 (USD MILLION)
    299. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, BY PRODUCT TYPE, 2018–2027
    300. (USD MILLION)
    301. MARKET, FOR HEMODYNAMIC MONITORING DEVICES, BY PRODUCT TYPE, 2018–2027 (USD
    302. MILLION)
    303. FOR NEUROMONITORING DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    304. INDIA: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR CARDIAC MONITORING
    305. DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    306. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR FETAL & NEONATAL MONITORING
    307. DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    308. PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, BY DEVICE TYPE, 2018–2027
    309. (USD MILLION)
    310. MARKET FOR RESPIRATORY MONITORING DEVICES, BY DISEASE INDICATION, 2018–2027
    311. (USD MILLION)
    312. MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    313. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR HEMODYNAMIC MONITORING
    314. DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    315. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR NEUROMONITORING DEVICES,
    316. BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    317. MONITORING AND VITAL SIGNS MODULES MARKET, FOR CARDIAC MONITORING DEVICES, BY PRODUCT
    318. TYPE, 2018–2027 (USD MILLION)
    319. AND VITAL SIGNS MODULES MARKET, FOR FETAL & NEONATAL MONITORING DEVICES, BY
    320. PRODUCT TYPE, 2018–2027 (USD MILLION)
    321. MONITORING AND VITAL SIGNS MODULES MARKET, BY DEVICE TYPE, 2018–2027 (USD
    322. MILLION)
    323. MARKET FOR RESPIRATORY MONITORING DEVICES, BY DISEASE INDICATION, 2018–2027
    324. (USD MILLION)
    325. MODULES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    326. KOREA: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR HEMODYNAMIC MONITORING
    327. DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    328. OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET, FOR NEUROMONITORING DEVICES,
    329. BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    330. MONITORING AND VITAL SIGNS MODULES MARKET, FOR CARDIAC MONITORING DEVICES, BY PRODUCT
    331. TYPE, 2018–2027 (USD MILLION)
    332. AND VITAL SIGNS MODULES MARKET, FOR FETAL & NEONATAL MONITORING DEVICES, BY
    333. PRODUCT TYPE, 2018–2027 (USD MILLION)
    334. MONITORING AND VITAL SIGNS MODULES MARKET, BY DEVICE TYPE, 2018–2027 (USD
    335. MILLION)
    336. MARKET FOR RESPIRATORY MONITORING DEVICES, BY DISEASE INDICATION, 2018–2027
    337. (USD MILLION)
    338. SIGNS MODULES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    339. REST OF ASIA PACIFIC: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET,
    340. FOR HEMODYNAMIC MONITORING DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    341. MARKET, FOR NEUROMONITORING DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    342. MARKET, FOR CARDIAC MONITORING DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)
    343. MARKET, FOR FETAL & NEONATAL MONITORING DEVICES, BY PRODUCT TYPE, 2018–2027
    344. (USD MILLION)
    345. SIGNS MODULES MARKET, BY DEVICE TYPE, 2018–2027 (USD MILLION)
    346. REST OF ASIA PACIFIC: OEM PATIENT MONITORING AND VITAL SIGNS MODULES MARKET FOR
    347. RESPIRATORY MONITORING DEVICES, BY

    OEM Patient Monitoring and Vital Sign OEM Module Market Segmentation

    OEM Patient Monitoring and Vital Sign OEM Module Product Type Outlook (USD Billion, 2018-2030)

    • Hemodynamic Monitoring Devices

      • Blood Glucose
      • Cholesterol
      • Blood Gas & Electrolyte Analyzers/Monitors
      • Blood Pressure

    • Neuromonitoring Devices

      • Electroencephalograph (EEG) Devices
      • Magnetoencephalograph (MEG) Devices
      • Intracranial Pressure Monitors (ICP)
      • Transcranial Dopplers (TCD)
      • Cerebral Oximeters
      • Near-infrared spectroscopy (NIRS)

    • Cardiac Monitoring Devices

      • Electrocardiogram (ECG) Devices
      • Implantable Loop Recorders (ILR)
      • Cardiac Output Monitoring (COM) Devices
      • Event Monitors

    • Fetal & Neonatal Monitoring Devices

      • Ultrasound
      • Electronic Fetal Monitoring Devices
      • Fetal Doppler Monitoring Devices
      • Other Fetal & Neonatal Monitoring Devices

    • Respiratory Monitoring Devices

      • Device Type

        • Capnographs
        • Anesthesia Monitors
        • Spirometers
        • Pulse Oximeters
        • Sleep Apnea Monitoring Devices

      • Disease Indication

        • COPD
        • Sleep Apnea
        • Asthma
        • Others
    • Remote Patient Monitoring Devices
    • Temperature Monitoring Devices
    • Others

    OEM Patient Monitoring and Vital Sign OEM Module Regional Outlook (USD Billion, 2018-2030)

    • North America Outlook (USD Billion, 2018-2030)

      • North America OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • US Outlook (USD Billion, 2018-2030)

      • US OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • Canada Outlook (USD Billion, 2018-2030)

      • Canada OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

    • Europe Outlook (USD Billion, 2018-2030)

      • Europe OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • Germany Outlook (USD Billion, 2018-2030)

      • Germany OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • France Outlook (USD Billion, 2018-2030)

      • France OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • UK Outlook (USD Billion, 2018-2030)

      • UK OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • Italy Outlook (USD Billion, 2018-2030)

      • Italy OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • Spain Outlook (USD Billion, 2018-2030)

      • Spain OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • Rest of Europe Outlook (USD Billion, 2018-2030)

      • Rest of Europe OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

    • Asia-Pacific Outlook (USD Billion, 2018-2030)

      • Asia-Pacific OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • China Outlook (USD Billion, 2018-2030)

      • China OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • Japan Outlook (USD Billion, 2018-2030)

      • Japan OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • India Outlook (USD Billion, 2018-2030)

      • India OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • South Korea Outlook (USD Billion, 2018-2030)

      • South Korea OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • Australia Outlook (USD Billion, 2018-2030)

      • Australia OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)

      • Rest of Asia-Pacific OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

    • Rest of the World Outlook (USD Billion, 2018-2030)

      • Rest of the World OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • Middle East Outlook (USD Billion, 2018-2030)

      • Middle East OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • Africa Outlook (USD Billion, 2018-2030)

      • Africa OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

      • Latin America Outlook (USD Billion, 2018-2030)

      • Latin America OEM Patient Monitoring and Vital Sign OEM Module by Product Type

        • Hemodynamic Monitoring Devices

          • Blood Glucose
          • Cholesterol
          • Blood Gas & Electrolyte Analyzers/Monitors
          • Blood Pressure

        • Neuromonitoring Devices

          • Electroencephalograph (EEG) Devices
          • Magnetoencephalograph (MEG) Devices
          • Intracranial Pressure Monitors (ICP)
          • Transcranial Dopplers (TCD)
          • Cerebral Oximeters
          • Near-infrared spectroscopy (NIRS)

        • Cardiac Monitoring Devices

          • Electrocardiogram (ECG) Devices
          • Implantable Loop Recorders (ILR)
          • Cardiac Output Monitoring (COM) Devices
          • Event Monitors

        • Fetal & Neonatal Monitoring Devices

          • Ultrasound
          • Electronic Fetal Monitoring Devices
          • Fetal Doppler Monitoring Devices
          • Other Fetal & Neonatal Monitoring Devices

        • Respiratory Monitoring Devices

          • Device Type

            • Capnographs
            • Anesthesia Monitors
            • Spirometers
            • Pulse Oximeters
            • Sleep Apnea Monitoring Devices

          • Disease Indication

            • COPD
            • Sleep Apnea
            • Asthma
            • Others
        • Remote Patient Monitoring Devices
        • Temperature Monitoring Devices
        • Others

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027